Arcturus Therapeutics Holdings (ARCT) Other financing activities (2018 - 2026)
Arcturus Therapeutics Holdings (ARCT) posted Other financing activities of $16000.0 for Q1 2026, down 86.21% on a QoQ basis from $116000.0 in Q3 2025, and down 91.79% year-over-year from $195000.0 in Q1 2025.
Arcturus Therapeutics Holdings (ARCT) Other financing activities (2018 - 2026) Analysis & Trends
Arcturus Therapeutics Holdings' Other financing activities history runs 9 years deep, the most recent figure standing at $16000.0 for Q1 2026.
- Quarterly Other financing activities fell 91.79% year-over-year to $16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $406000.0 (down 85.2% YoY) and the FY2025 annual result came in at $585000.0, down 87.65% from the prior year.
- Other financing activities was $16000.0 for Q1 2026 at Arcturus Therapeutics Holdings, down from $116000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $4.1 million in Q4 2024 and bottomed at -$3.9 million in Q3 2024.
- A 5-year average of $688642.9 and a median of $352500.0 in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2022 — Other financing activities jumped 589.17% — and 2024, when it slumped 859.03%.
- Arcturus Therapeutics Holdings' Other financing activities stood at $768000.0 in 2022, then soared by 168.1% to $2.1 million in 2023, then surged by 96.89% to $4.1 million in 2024, then sank by 97.14% to $116000.0 in 2025, then sank by 86.21% to $16000.0 in 2026.
- Business Quant data shows ARCT's Other financing activities at $16000.0 in Q1 2026, $116000.0 in Q3 2025, and $274000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcturus Therapeutics Holdings | 164.57 Mn | -46.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 274,000.00 |
| Mar 31, 2025 | 195,000.00 |
| Mar 31, 2025 | 195,000.00 |
| Dec 31, 2024 | 4.05 Mn |
| Dec 31, 2024 | 4.05 Mn |
| Sep 30, 2024 | -3.91 Mn |
| Sep 30, 2024 | -3.91 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Jun 30, 2024 | 2.40 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Mar 31, 2024 | 2.19 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Dec 31, 2023 | 2.06 Mn |
| Sep 30, 2023 | 515,000.00 |
| Sep 30, 2023 | 515,000.00 |